Edward Borkowski - 03 Jan 2022 Form 4 Insider Report for First Wave BioPharma, Inc. (ENTO)

Role
Director
Signature
/s/ Edward Borkowski
Issuer symbol
ENTO
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
03 Jan 2022, 20:07:25 UTC
Previous filing
02 Jul 2021
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FWBI Stock option (right to buy) Award $0 +34,482 $0.000000 34,482 03 Jan 2022 Common stock, par value $0.0001 per share 34,482 $1.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in equal quarterly installments on each of March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.